Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/324234
Type: Artigo
Title: Accessing The Chemical Profile Of Ecstasy Tablets Seized In São Paulo (brazil) By Ft-raman Spectroscopy
Author: Moreira R.V.
da Costa J.L.
Menezes M.R.
de Faria D.L.A.
Abstract: FT-Raman spectroscopy was used in the chemical analysis of ecstasy tablets seized in the State of São Paulo (Brazil) and GC–MS was used as confirmatory technique. The main purpose was to obtain information about the drug source or distribution routes, as well as to access the potential health risks for users from their chemical composition. Previous works have shown that only ca. 45% of the ecstasy tablet seized in São Paulo contained 3,4-methylenedioxymethamphetamine (MDMA or 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine); however, in the spectra reported here no MDMA was identified. Caffeine, methorphan (dextromethorphan), a βk-MDMA analog and clobenzorex were detected instead; clobenzorex was identified in orange tablets that also contained an unknown chemical compound with unassigned Raman bands, which was not detected by GC–MS. An identification of the chemical compounds present in red tablets was not possible by matching the band positions to any of the possibilities considered, including pharmaceuticals. The residue left after methanol dissolution was analyzed by FT-Raman spectroscopy, and titanium dioxide (anatase), starch and microcrystalline cellulose were identified. © 2016 Elsevier B.V.
Subject: Design Drug
Drug Cuts
Ecstasy
Ft-raman
New Psychoactive Substances
Editor: Elsevier
Rights: fechado
Identifier DOI: 10.1016/j.vibspec.2016.09.015
Address: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988697069&doi=10.1016%2fj.vibspec.2016.09.015&partnerID=40&md5=5717fdef979646518e52029d76f23220
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
2-s2.0-84988697069.pdf477.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.